New Zealand King Salmon Investments Limited is pleased to advise the annual report for the year ended 31 January 2022 is now available.
An electronic copy is attached, and is also available at our website, www.kingsalmon.co.nz/investors
Contact:
Grant Rosewarne, Managing Director and CEO, New Zealand King Salmon Investments Ltd, [email protected]
Ben Rodgers, CFO and Company Secretary, New Zealand King Salmon Investments Ltd, [email protected]
The S&P/ASX 200 has recovered from the US's so-called "Liberation Day".
It will close at the end of July, affecting 120 jobs.
The median price for Cxbladder Triage Plus is US$1,018.44.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details